Is ENTO stock a buy?
What Is The Conclusion?
Right now our advanced algorithms say:
Do the analyst corps agree?
Interesting Questions and Easy Answers!
We cannot find any recorded dividends paid in our systems.
Sorry, we do not have any analyst data for this ticker
On Thursday 26th of April 2012, Entero Therapeutics, Inc. had a stock price of $0.0070. If you invested back then, your return now would be a profit of $0.567 per share or 8 101.43%
No, the average daily trading liquidity for Entero Therapeutics, Inc. is $248 575 thousand. Trading in stocks with this little trading liquidity is very dangerous, and you can get into a situation where it will be hard to trade your stocks. In addition, these types of stocks usually have very high volatility.
Entero Therapeutics, Inc. has little of the business financed by loans. This puts the company at lower risk in periods of high inflation where borrowing costs usually go up. The company is still not profitable, and high inflation will make it harder to become profitable as costs increase and consumer spending decreases.
We have calculated the inflation risk for Entero Therapeutics, Inc. to be medium [0.6 out of 1]